CRISPR base editor treats premature-aging syndrome
作者机构:Wound Trauma Medical CenterState Key Laboratory of TraumaBurns and Combined InjuryDaping HospitalArmy Medical UniversityChongqingChina Department of Biomedical SciencesSchool of Medicine and Health SciencesUniversity of North DakotaGrand ForksNDUSA
出 版 物:《Signal Transduction and Targeted Therapy》 (信号转导与靶向治疗(英文))
年 卷 期:2021年第6卷第5期
页 面:1410-1412页
核心收录:
学科分类:0710[理学-生物学] 07[理学] 071008[理学-发育生物学]
基 金:This work is supported by National Nature Science Foundation of China Grants 32000033,82020108021 and 81530063 this work is also supported by National Institutes of Health Grants R01 All09317-01A1 and R01 AI138203 this work is also supported by The American Association of Immunologists through a Careers in Immunology Fellowship
摘 要:A recent paper published in Nature by Koblan et *** the use of CRISPR-mediated adenine base editor(ABE)to repair mutations of the Hutchinson-Gilford progeria syndrome(HGPS or progeria),attenuate symptoms,and extend lifespan of mice(Fig.1),representing a major advance in design of treatments for human accelerated-ageing disorders and potentially other genetic diseases.